We are live on ! Find out more
EWM

Elite Wealth Management Portfolio holdings

AUM $308M
1-Year Est. Return 30.88%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+30.88%
3 Year Est. Return
+130.3%
5 Year Est. Return
+130.18%
10 Year Est. Return
AUM
$137M
AUM Growth
+$23.2M
Cap. Flow
+$15.6M
Cap. Flow %
11.43%
Top 10 Hldgs %
48.65%
Holding
1,007
New
568
Increased
105
Reduced
87
Closed
111

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.87M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.19M
3
F icon
Ford
F
+$2.88M
4
PM icon
Philip Morris
PM
+$2.78M
5
APA icon
APA Corp
APA
+$2.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.66M
2
NOV icon
NOV
NOV
+$1.99M
3
TXN icon
Texas Instruments
TXN
+$1.81M
4
RTX icon
RTX Corp
RTX
+$1.81M
5
ALL icon
Allstate
ALL
+$1.78M

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.82%
3 Financials 9.13%
4 Consumer Staples 8.35%
5 Healthcare 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
476
CALL
KeyCorp
KEY
$24.2B
$4K ﹤0.01%
67
LRCX icon
477
Lam Research
LRCX
$372B
$4K ﹤0.01%
+760
New +$4K
LYG icon
478
Lloyds Banking Group
LYG
$90.7B
$4K ﹤0.01%
+675
New +$3.39K
M icon
479
Macy's
M
$6.56B
$4K ﹤0.01%
78
MA icon
480
Mastercard
MA
$510B
$4K ﹤0.01%
+50
New +$3.71K
MUR icon
481
Murphy Oil
MUR
$5.48B
$4K ﹤0.01%
+55
New +$3.45K
NOC icon
482
Northrop Grumman
NOC
$76B
$4K ﹤0.01%
+31
New +$3.32K
NOV icon
483
NOV
NOV
$6.93B
$4K ﹤0.01%
50
-27,434
-100% -$1.99M
PBR icon
484
Petrobras
PBR
$123B
$4K ﹤0.01%
+305
New +$4.73K
PG icon
485
CALL
Procter & Gamble
PG
$335B
$4K ﹤0.01%
+83
New +$6.76K
PPG icon
486
PPG Industries
PPG
$25B
$4K ﹤0.01%
+44
New +$3.96K
PSLV icon
487
Sprott Physical Silver Trust
PSLV
$12.2B
$4K ﹤0.01%
499
SABA
488
Saba Capital Income & Opportunities Fund II
SABA
$223M
$4K ﹤0.01%
+250
New +$4.08K
SBGI icon
489
Sinclair Inc
SBGI
$994M
$4K ﹤0.01%
+125
New +$4.2K
STT icon
490
State Street
STT
$50.2B
$4K ﹤0.01%
+51
New +$3.57K
TGNA
491
DELISTED
TEGNA Inc
TGNA
$4K ﹤0.01%
+233
New +$3.29K
TRMB icon
492
Trimble
TRMB
$13.3B
$4K ﹤0.01%
+126
New +$3.97K
GPOR
493
PUT
DELISTED
Gulfport Energy Corp.
GPOR
$4K ﹤0.01%
+592
New +$35.9K
CHK
494
DELISTED
Chesapeake Energy Corporation
CHK
$4K ﹤0.01%
+1
New +$5.08K
ASNA
495
DELISTED
Ascena Retail Group, Inc.
ASNA
$4K ﹤0.01%
+10
New +$4.08K
APU
496
DELISTED
AmeriGas Partners, L.P.
APU
$4K ﹤0.01%
+100
New +$4.35K
BBG
497
DELISTED
Bill Barrett Corp
BBG
$4K ﹤0.01%
+152
New +$4.14K
VAL
498
DELISTED
Valspar
VAL
$4K ﹤0.01%
+57
New +$3.95K
STJ
499
DELISTED
St Jude Medical
STJ
$4K ﹤0.01%
+67
New +$3.88K
FBC
500
PUT
DELISTED
Flagstar Bancorp, Inc. New
FBC
$4K ﹤0.01%
+231
New +$3.92K

Similar funds

Elite Wealth Management's Q4 2013 Portfolio in Review

As of Q4 2013, Elite Wealth Management held 1,007 positions worth $137M, up 20% from $113M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Elite Wealth Management deployed $15.6M of net new capital in Q4 2013, opening 568 new positions and adding to 105 existing holdings. Its largest new stake was Union Pacific: 12,440 shares worth $1.04M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $2.66M trimmed.

  • Elite Wealth Management's largest Q4 2013 buy was Union Pacific: 12,440 shares worth $1.04M.
  • Elite Wealth Management added most to Johnson & Johnson in Q4 2013, an estimated $3.87M increase.
  • Elite Wealth Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $2.66M.
  • Elite Wealth Management fully exited Texas Instruments in Q4 2013, selling an estimated $1.81M.
  • Elite Wealth Management's ten largest holdings make up 49% of its $137M portfolio in Q4 2013.
  • Elite Wealth Management opened 568 new positions and closed 111 in Q4 2013.
  • Elite Wealth Management's portfolio value rose 20% quarter-over-quarter to $137M.

Based on Elite Wealth Management's 13F filing for Q4 2013, filed 23 Nov 2016.